General Information of Drug (ID: DM1ZK4W)

Drug Name
TRBC1 Drug Info
Indication
Disease Entry ICD 11 Status REF
Anaplastic large cell lymphoma 2A90.A Phase 1/2 [1]
Angioimmunoblastic T-cell Lymphoma 2A90.9 Phase 1/2 [1]
Non-hodgkin lymphoma 2B33.5 Phase 1/2 [1]
Peripheral T-cell lymphoma 2A90.C Phase 1/2 [1]
Cross-matching ID
TTD Drug ID
DM1ZK4W

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
T-cell receptor beta constant 1 (TRBC1) TT1DHW2 TRBC1_HUMAN CAR-T-Cell-Therapy [1]

References

1 ClinicalTrials.gov (NCT03590574) Phase I/II Study Evaluating AUTO4 in Patients With TRBC1 Positive T Cell Lymphoma